NYSE: ACHAccendra Health Inc Stock
$2.61+0.13 (+5.24%)
Updated Feb 20, 2026
ACH Price
$2.61
Fair Value Price
N/A
Market Cap
$199.50M
52 Week Low
$1.84
52 Week High
$10.43
P/E
-0.18x
P/B
-0.43x
P/S
0.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.76B
Earnings
-$1.10B
Gross Margin
46.7%
Operating Margin
-35.94%
Profit Margin
-39.8%
Debt to Equity
-6.32
Operating Cash Flow
-$102M
Beta
1.24
Next Earnings
Feb 25, 2026
Ex-Dividend
N/A
Next Dividend
N/A
ACH Overview
Owens & Minor, Inc. distributes consumable medical-surgical supplies to healthcare providers in the U.S. and internationally. Owens & Minor was founded in 1882 and is headquartered in Richmond, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ACH's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Distribution
Industry Rating
A
ACH
Ranked#6 of 6
Ranked#6 of 6
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $224.44 | B | |
| $79.57 | B | |
| $947.48 | B |
Be the first to know about important ACH news, forecast changes, insider trades & much more!
ACH News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ACH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ACH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACH is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ACH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 35 more ACH due diligence checks available for Premium users.
Valuation
ACH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.18x
Industry
32.43x
Market
44.63x
ACH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.43x
Industry
288.26x
ACH's financial health
Profit margin
Revenue
$709.0M
Net Income
-$56.3M
Profit Margin
-7.9%
ACH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ACH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.5B
Liabilities
$2.9B
Debt to equity
-6.32
ACH's short-term liabilities ($947.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACH's long-term liabilities ($1.97B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ACH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$68.2M
Investing
$285.0M
Financing
-$117.5M
ACH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ACH vs Medical Distribution Stocks
Accendra Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.